Co-Diagnostics, Inc. - Hold
Zacks' proprietary data indicates that Co-Diagnostics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CODX shares relative to the market in the next few months. In addition, Co-Diagnostics, Inc. has a VGM Score of F (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Co-Diagnostics, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of CODX, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.
Style Scorecard
Value Scorecard
Growth Scorecard
Momentum Scorecard
Value Score | CODX: F | Industry [X] | ICCM: F | OCX: F | INBS: F |
---|---|---|---|---|---|
Zacks Rank | 3 | 2 | 2 | 3 | |
VGM Score | F | D | F | F | |
Cash/Price | 1.18 | 0.14 | 0.32 | 0.20 | 1.61 |
EV/EBITDA | 0.21 | 0.51 | -1.64 | -0.95 | 0.63 |
PEG Ratio | NA | 1.55 | NA | NA | NA |
Price/Book (P/B) | 0.54 | 1.82 | 2.94 | 2.38 | 0.48 |
Price/Cash Flow (P/CF) | NA | 12.86 | NA | NA | NA |
P/E (F1) | NA | 20.22 | NA | NA | NA |
Price/Sales (P/S) | 6.32 | 1.22 | 10.49 | 19.93 | 2.06 |
Earnings Yield | -98.52% | 3.21% | -37.33% | -77.48% | -66.84% |
Debt/Equity | 0.00 | 0.01 | 0.03 | 0.00 | 0.01 |
Cash Flow ($/share) | -1.12 | -0.03 | -0.31 | -3.74 | -8.05 |
Growth Score | CODX: F | Industry [X] | ICCM: C | OCX: F | INBS: C |
---|---|---|---|---|---|
Zacks Rank | 3 | 2 | 2 | 3 | |
VGM Score | F | D | F | F | |
Hist. EPS Growth | NA | 5.97% | NA% | NA% | NA% |
Proj. EPS Growth | -10.83% | 15.73% | 14.06% | 40.96% | 65.94% |
Curr. Cash Flow Growth | -508.47% | -14.35% | -14.35% | -681.84% | -81.19% |
Hist. Cash Flow Growth | NA | 13.40% | NA% | NA% | NA% |
Current Ratio | 10.19 | 1.63 | 3.39 | 0.78 | 2.02 |
Debt/Capital | 0.00% | 28.75% | 2.61% | 0.00% | 1.35% |
Net Margin | -582.36% | -8.83% | -444.30% | -2,905.14% | -354.86% |
Return on Equity | -42.35% | -10.51% | -101.66% | -135.45% | -210.36% |
Sales/Assets | 0.07 | 0.55 | 0.17 | 0.02 | 0.25 |
Proj. Sales Growth (F1/F0) | -76.51% | 0.00% | 24.50% | 0.00% | NA% |
Momentum Score | CODX: F | Industry [X] | ICCM: D | OCX: D | INBS: D |
---|---|---|---|---|---|
Zacks Rank | 3 | 2 | 2 | 3 | |
VGM Score | F | D | F | F | |
Daily Price Chg | 3.85% | 0.08% | -99,999.00% | 5.71% | -0.53% |
1 Week Price Chg | 8.00% | 1.43% | 2.74% | 9.90% | 2.19% |
4 Week Price Chg | -15.09% | 0.00% | -8.42% | 20.65% | -9.22% |
12 Week Price Chg | 17.39% | 0.00% | -38.02% | 33.20% | -31.75% |
52 Week Price Chg | 0.00% | -32.79% | -43.18% | -23.38% | -94.78% |
20 Day Average Volume | 102,734 | 130,919 | 140,419 | 71,125 | 30,752 |
(F1) EPS Est. Wkly Chg | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
(F1) EPS Est. Mthly Chg | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
(F1) EPS Est. Qtrly Chg | -34.34% | -0.41% | 3.51% | 0.00% | 0.00% |
(Q1) EPS Est. Mthly Chg | 0.00% | 0.00% | 0.00% | NA% | NA% |
Zacks News for CODX
Icon PLC (ICLR) Q4 Earnings Surpass Estimates
CODX: What are Zacks experts saying now?
Zacks Private Portfolio Services